Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Total Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1020596C details a novel stereoselective route for epipodophyllotoxin intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel total synthesis route for amide alkaloids offers high yield and scalable production for pharmaceutical research and commercial supply chains.
Novel synthetic route for anti-fibrosis compound. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates globally.
Patent CN115197058A reveals a novel total synthesis of anticancer Dysideanone B. Discover cost-effective manufacturing routes and supply chain advantages for pharmaceutical intermediates.
Novel total synthesis of Protosappanin A derivatives. High yield, mild conditions, scalable for pharmaceutical intermediates and natural pigment supply chains.
Patent CN105663112A reveals a novel total synthesis route for Morusignin L. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN1087090A reveals a novel total synthesis route for 11 beta substituted estradiene compounds, offering significant supply chain stability and cost advantages.
Patent CN102976924B reveals asymmetric synthesis for high-purity intermediates. Enables cost reduction and supply chain reliability for global pharmaceutical manufacturing partners.
Novel total synthesis of houttuynoid hybrid flavonoids via Pd-catalyzed coupling and oxidative cyclization, offering scalable production for antiviral drug development.
Patent CN106632368A reveals a scalable total synthesis route for Irinotecan Hydrochloride, ensuring high purity and supply chain stability for global API manufacturers.
New patent route for Trabectedin intermediates reduces steps and cost. Scalable synthesis from L-tyrosine ensures supply chain stability for global pharma.
Innovative 11-step synthetic route for high-purity H4 alkaloid ensures scalable supply for NAFLD therapeutics, overcoming natural extraction limitations effectively.
Novel 7-step total synthesis of estrone from tetralone offers high purity and cost efficiency for pharmaceutical intermediate manufacturing supply chains.
Novel Pictet-Spengler and Heck coupling strategy enables scalable production of anti-inflammatory alkaloid Arbornamine with improved cost efficiency.
Patent CN117645594A details a low-cost total synthesis of Oroxylin A. This route offers significant supply chain stability and cost reduction in API manufacturing.
Advanced asymmetric synthesis of tetrahydroxanthone dimers via patent CN107216306A. Enhances supply chain reliability and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110776488B details an efficient 8-step asymmetric synthesis of (-)-Brazilin. Discover cost-effective manufacturing strategies for this bioactive natural product.
Patent CN103396390A reveals a cost-effective total synthesis of strigolactone GR24 using 1-indanone, offering high purity and simplified supply chain for agricultural applications.
Patent CN111662260B reveals a 7-step synthesis of saffloneoside. Offers stable intermediates and scalable routes for cerebral ischemia drug development.
Patent CN102827002A details a robust total synthesis of Salvianolic Acid A, offering a stable alternative to plant extraction for reliable pharmaceutical intermediate supply chains.